Explained | Why Paracetamol, Antacids, And Other Common Indian Drugs Are Failing Quality Tests?
India's top drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has recently raised alarms by flagging more than 50 common medications. These include everyday drugs like Paracetamol, the antacid Pan-D, and Vitamin D3 supplements, which millions of Indians use regularly. This has caused concerns about drug safety and quality across the country.
What's Happening?

The CDSCO conducted random quality tests on various medicines and found that several popular drugs, including painkillers, antibiotics, and vitamins, did not meet the required safety and quality standards. Among these drugs were Paracetamol tablets, a diabetes medication called Glimepiride, and a high blood pressure drug named Telma H.
Even everyday supplements like Shelcal, which is used for calcium and Vitamin D3, and Pan-D for acid reflux, were found to be substandard. Some commonly used antibiotics, such as Metronidazole and Clavam 625, which are used to treat bacterial infections, also failed the tests.
Indian Drugs Are Failing Quality Tests - Why Is This a Big Deal?
These findings are concerning because the flagged drugs are widely used in Indian households. People rely on these medications for common health issues like pain, fever, and digestion problems. If the quality of these drugs is poor, it can affect people's health and treatment outcomes.
Even non-medicine items, like a type of gauze used in medical procedures, failed the quality tests. Some Ayurvedic products like Haridrakhandam and Yogaraja Guggulu also did not meet the necessary standards.
This news comes just after the CDSCO banned 156 fixed-dose drug combinations in August, which included commonly used drugs for colds, fevers, and allergies. This has raised bigger questions about the overall safety of drugs in India.
What Do Drug Companies Say?
Several major pharmaceutical companies, including Sun Pharma and Glenmark, have denied responsibility for the flagged drugs. They claim that the problematic batches may be counterfeit or fake versions of their products. Investigations are ongoing to confirm if the drugs that failed the tests were genuinely produced by these companies or not.
Why Does It Matter?
Ensuring the quality of medicines is vital to keep people safe and healthy. Poor-quality drugs can lead to ineffective treatments, worsening health problems, or even harmful side effects. By identifying and removing substandard medicines, regulators can protect public health.
Consumers are advised to stay updated on these developments and consult healthcare professionals if they have concerns about the medicines they are using.
-
Karnataka Weather Alert: Pre-Monsoon Rains Likely in Bengaluru Next Week Before Summer Intensifies -
Tamil Nadu Election Dates: EC Set To Announce Polling & Counting Dates -
‘Do Not Interfere’: Donald Trump Says US Hit Iran’s Kharg Island, Warns He Will Act If Shipping Is Threatened -
Iran Nuclear Crisis: Putin’s Uranium Transfer Plan Fails to Gain US Support -
Bigg Boss Fame Vada Pav Girl Sparks Debate After Saying 'Will Sleep With Anyone For Money To Raise My Child' -
NZ vs SA T20I Series 2026: New Zealand vs South Africa Series Date, Time, Venue and Live Streaming Details -
Tamil Nadu Polls 2026: TVK Rules Out Alliance With BJP-led NDA -
What Is Google Doodle Today? The Story Behind Pi Day 2026 -
D-Mart Staff Mocks Breastfeeding Woman, Says “Doodh Piyega?” in Public; Video Goes Viral -
Japan Confirms North Korea Fired Suspected Ballistic Missile Toward East Sea, Activates Crisis Response Team -
Iran Allows Safe Passage For Two Indian LPG Carriers Through Strait Of Hormuz Amid US Conflict -
Emergency! Japan Issues Alert After Suspected North Korean Ballistic Missile Launch












Click it and Unblock the Notifications